MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ETZOLD, G.
Right arrow Articles by LANGEN, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ETZOLD, G.
Right arrow Articles by LANGEN, P.

Molecular Pharmacology, Vol 4, 20-24, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Structural Requirements for the Inhibition of Uridine-Deoxyuridine Phosphorylase by Thymine Nucleosides Containing an Unnatural Carbohydrate Moiety

G. ETZOLD 1, B. PREUSSEL 1, and P. LANGEN 1

1 Institute of Biochemistry, German Academy of Sciences Berlin, Berlin-Buch, Germany (G. D. R.)

1-(2'-Deoxy-beta-D-xylopyranosyl) thymine (beta-II) produces as great an inhibitory effect on uridine-deoxyuridine phosphorylase as 1-(2'-deoxy-beta-D-glucopyranosyl)thymine (beta-I), whereas the inhibitory action of 1-(2'-deoxy-beta-D-xylofuranosyl)thymine (V) is only 1/25 that of the above-mentioned beta-nucleosides. The inhibitory activity of 1-(2'-deoxy-agr-D-xylopyranosyl) thymine (agr-II) is equal to that of 1-(2'-deoxy-agr-D-glucopyranosyl)thymine (agr-I), both being less effective than the corresponding beta-anomers and more active than V. agr- and beta-1-(2'-Deoxy-D-ribopyranosyl)thymine (agr-III and beta-III) are noninhibitory under the same conditions. Hence, both the presence of a pyranose lactol ring and the xylo configuration of time hydroxyl group C-3' are necessary for the inhibitory action of these compounds. 1-(Tetrahydro-2'-pyranyl)thymine (VI) is not active.

Note:
ACKNOWLEDGMENTS We are grateful to Professor Charles Heidelberger, McArdle Laboratory for Cancer Research, University of Wisconsin, for his valuable advice in the preparation of this manuscript. The skillful technical assistance of Miss R. Wohlfeil is acknowledged.

Submitted on January 23, 1967
Revised on August 7, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics